The present disclosure is directed to methods for treating diseases for which cysteamine is indicated and compounds useful in such methods.
本公开涉及治疗半胱胺可用于治疗的疾病的方法以及在这些方法中有用的化合物。
ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF
申请人:Horizon Orphan LLC
公开号:EP3316877B1
公开(公告)日:2019-10-30
[EN] ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF<br/>[FR] ANALOGUES DE LA CYSTÉAMINE RÉSISTANT À L'ADO ET UTILISATIONS DE CEUX-CI
申请人:RAPTOR PHARMACEUTICALS INC
公开号:WO2017004485A1
公开(公告)日:2017-01-05
The present invention is directed to ADO-resistant cysteamine analogs for use in methods of treating diseases for which cysteamine is indicated, in particular cystinosis, fatty liver disease, fibrosis, thrombotic diseases, MECP-2 related disorders, inherited mitochondrial diseases, neurological diseases or disorders, inflammation and cancer.
Franzen, Chemische Berichte, 1957, vol. 90, p. 2036